Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Bimatoprost Ophthalmic
DRUG
4 trials
Sponsors
Johns Hopkins University
, Salus University
, Laboratoires Thea
Conditions
Glaucoma
Graves Ophthalmopathy
Healthy Volunteers
Normal Tension Glaucoma
Ocular Hypertension
Early Phase 1
Bimatoprost as a Treatment for Graves' Orbitopathy
Recruiting
NCT03708627
Johns Hopkins University
Graves Ophthalmopathy
Start: 2017-11-01
End: 2031-07-01
Target: 3
Updated: 2026-07-16
Phase 1
Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers
Completed
NCT05729594
Laboratoires Thea
Healthy Volunteers
Start: 2023-02-27
End: 2023-04-05
Updated: 2023-11-14
Phase 3
Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients
Completed
NCT05397600
Laboratoires Thea
Glaucoma, Ocular Hypertension
Start: 2022-06-22
End: 2024-03-07
Updated: 2024-07-18
Phase 4
Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma
NCT04981886
Salus University
Normal Tension Glaucoma
Start: 2021-08-31
End: 2022-08-31
Target: 115
Updated: 2021-08-06